These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 26456145)

  • 41. Cell Adhesion Molecule CD166 Drives Malignant Progression and Osteolytic Disease in Multiple Myeloma.
    Xu L; Mohammad KS; Wu H; Crean C; Poteat B; Cheng Y; Cardoso AA; Machal C; Hanenberg H; Abonour R; Kacena MA; Chirgwin J; Suvannasankha A; Srour EF
    Cancer Res; 2016 Dec; 76(23):6901-6910. PubMed ID: 27634757
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Native osteoprotegerin gene transfer inhibits the development of murine osteolytic bone disease induced by tumor xenografts.
    Doran PM; Turner RT; Chen D; Facteau SM; Ludvigson JM; Khosla S; Riggs BL; Russell SJ
    Exp Hematol; 2004 Apr; 32(4):351-9. PubMed ID: 15050745
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Computer-assisted technique to delineate osteolytic lesions around the femoral component in total hip arthroplasty.
    Prevrhal S; Klifa CS; Shepherd JA; Ries MD; Genant HK
    J Arthroplasty; 2008 Sep; 23(6):833-8. PubMed ID: 18534519
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Volumetric computerized tomography as a measurement of periprosthetic acetabular osteolysis and its correlation with wear.
    Looney RJ; Boyd A; Totterman S; Seo GS; Tamez-Pena J; Campbell D; Novotny L; Olcott C; Martell J; Hayes FA; O'Keefe RJ; Schwarz EM
    Arthritis Res; 2002; 4(1):59-63. PubMed ID: 11879538
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Inhibiting Dickkopf-1 (Dkk1) removes suppression of bone formation and prevents the development of osteolytic bone disease in multiple myeloma.
    Heath DJ; Chantry AD; Buckle CH; Coulton L; Shaughnessy JD; Evans HR; Snowden JA; Stover DR; Vanderkerken K; Croucher PI
    J Bone Miner Res; 2009 Mar; 24(3):425-36. PubMed ID: 19016584
    [TBL] [Abstract][Full Text] [Related]  

  • 46. HaloJ: an ImageJ program for semiautomatic quantification of DNA damage at single-cell level.
    Maurya DK
    Int J Toxicol; 2014; 33(5):362-6. PubMed ID: 25201898
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Open source software for semi-automated histomorphometry of bone resorption and formation parameters.
    van 't Hof RJ; Rose L; Bassonga E; Daroszewska A
    Bone; 2017 Jun; 99():69-79. PubMed ID: 28366796
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Differences in the cytokine profiles associated with prostate cancer cell induced osteoblastic and osteolytic lesions in bone.
    Lee Y; Schwarz E; Davies M; Jo M; Gates J; Wu J; Zhang X; Lieberman JR
    J Orthop Res; 2003 Jan; 21(1):62-72. PubMed ID: 12507581
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A versatile macro-based neurohistological image analysis suite for ImageJ focused on automated and standardized user interaction and reproducible data output.
    Timothy M; Forlano PM
    J Neurosci Methods; 2019 Aug; 324():108286. PubMed ID: 31063801
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Liver volumetry plug and play: do it yourself with ImageJ.
    Dello SA; van Dam RM; Slangen JJ; van de Poll MC; Bemelmans MH; Greve JW; Beets-Tan RG; Wigmore SJ; Dejong CH
    World J Surg; 2007 Nov; 31(11):2215-21. PubMed ID: 17726630
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Inhibition of p38alpha mitogen-activated protein kinase prevents the development of osteolytic bone disease, reduces tumor burden, and increases survival in murine models of multiple myeloma.
    Vanderkerken K; Medicherla S; Coulton L; De Raeve H; Willems A; Lawson M; Van Camp B; Protter AA; Higgins LS; Menu E; Croucher PI
    Cancer Res; 2007 May; 67(10):4572-7. PubMed ID: 17495322
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cathepsin G enhances mammary tumor-induced osteolysis by generating soluble receptor activator of nuclear factor-kappaB ligand.
    Wilson TJ; Nannuru KC; Futakuchi M; Sadanandam A; Singh RK
    Cancer Res; 2008 Jul; 68(14):5803-11. PubMed ID: 18632634
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Osteoprotegerin inhibits osteolysis and decreases skeletal tumor burden in syngeneic and nude mouse models of experimental bone metastasis.
    Morony S; Capparelli C; Sarosi I; Lacey DL; Dunstan CR; Kostenuik PJ
    Cancer Res; 2001 Jun; 61(11):4432-6. PubMed ID: 11389072
    [TBL] [Abstract][Full Text] [Related]  

  • 54. SRC kinase inhibition with saracatinib limits the development of osteolytic bone disease in multiple myeloma.
    Heusschen R; Muller J; Binsfeld M; Marty C; Plougonven E; Dubois S; Mahli N; Moermans K; Carmeliet G; Léonard A; Baron F; Beguin Y; Menu E; Cohen-Solal M; Caers J
    Oncotarget; 2016 May; 7(21):30712-29. PubMed ID: 27095574
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Assessing treatment response of osteolytic lesions by manual volumetry, automatic segmentation, and RECIST in experimental bone metastases.
    Bretschi M; Fränzle A; Merz M; Hillengass J; Semmler W; Bendl R; Bäuerle T
    Acad Radiol; 2014 Sep; 21(9):1177-84. PubMed ID: 24998693
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Trolox inhibits osteolytic bone metastasis of breast cancer through both PGE2-dependent and independent mechanisms.
    Lee JH; Kim B; Jin WJ; Kim JW; Kim HH; Ha H; Lee ZH
    Biochem Pharmacol; 2014 Sep; 91(1):51-60. PubMed ID: 24929117
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Inhibition of bone resorption, rather than direct cytotoxicity, mediates the anti-tumour actions of ibandronate and osteoprotegerin in a murine model of breast cancer bone metastasis.
    Zheng Y; Zhou H; Brennan K; Blair JM; Modzelewski JR; Seibel MJ; Dunstan CR
    Bone; 2007 Feb; 40(2):471-8. PubMed ID: 17092788
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Segmentation and visualization of a large, high-resolution micro-CT data of mice.
    Chityala R; Pudipeddi S; Arensten L; Hui S
    J Digit Imaging; 2013 Apr; 26(2):302-8. PubMed ID: 22766797
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Selective tyrosine kinase inhibition of insulin-like growth factor-1 receptor inhibits human and mouse breast cancer-induced bone cell activity, bone remodeling, and osteolysis.
    Logan JG; Sophocleous A; Marino S; Muir M; Brunton VG; Idris AI
    J Bone Miner Res; 2013 May; 28(5):1229-42. PubMed ID: 23239200
    [TBL] [Abstract][Full Text] [Related]  

  • 60. ImageJ macros for the user-friendly analysis of soft-agar and wound-healing assays.
    Nunes JPS; Dias AAM
    Biotechniques; 2017 Apr; 62(4):175-179. PubMed ID: 28403808
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.